Company Filing History:
Years Active: 1989-1992
Title: Kenji Tani - Innovator in Biochemical Substrates
Introduction
Kenji Tani is a distinguished inventor based in Koriyama, Japan, known for his significant contributions to the field of biochemistry. With a focus on developing novel substrates for measuring biological components, Tani has been instrumental in advancing diagnostic methods for renal disorders.
Latest Patents
Tani holds two patents, including innovative glucosamine derivatives and compositions. His latest patents feature a novel phenylazonaphthol derivative, which serves as an excellent substrate for determining N-acetyl-.beta.-D-glucosaminidase (NAG) activity in urine. This substrate is characterized by high water solubility and resistance to interferences in urine, providing a straightforward method for NAG activity determination suitable for both rate and endpoint assays. Additionally, he has developed a novel substrate for plasma kallikrein measurement, represented by a specific general formula, which is useful in assessing various biological components.
Career Highlights
Kenji Tani is currently employed at Nitto Boseki Co., Ltd., where he continues to innovate and contribute to the field of biochemistry. His work has led to advancements in diagnostic techniques that are crucial for understanding and treating renal disorders.
Collaborations
Throughout his career, Tani has collaborated with notable colleagues, including Takeshi Nagasawa and Yoshio Nakamura. These partnerships have